LV10185B - Anti-vomit and sedative preparation for prevention of seasickness - Google Patents

Anti-vomit and sedative preparation for prevention of seasickness Download PDF

Info

Publication number
LV10185B
LV10185B LVP-93-627A LV930627A LV10185B LV 10185 B LV10185 B LV 10185B LV 930627 A LV930627 A LV 930627A LV 10185 B LV10185 B LV 10185B
Authority
LV
Latvia
Prior art keywords
pct
methyl
prevention
seasickness
vomit
Prior art date
Application number
LVP-93-627A
Other languages
English (en)
Latvian (lv)
Other versions
LV10185A (lv
Inventor
Gy Rgy Bodo
Jozsef Knoll
Eva Somfai
Sandor Virag
Ferenc Zak
Original Assignee
Chinoin Gyegyszer S Vegy Szeti
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chinoin Gyegyszer S Vegy Szeti filed Critical Chinoin Gyegyszer S Vegy Szeti
Publication of LV10185A publication Critical patent/LV10185A/xx
Publication of LV10185B publication Critical patent/LV10185B/lv

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Epidemiology (AREA)
  • Otolaryngology (AREA)
  • Anesthesiology (AREA)
  • Hospice & Palliative Care (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Lubricants (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Fodder In General (AREA)
  • General Preparation And Processing Of Foods (AREA)
  • Confectionery (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Connection Of Batteries Or Terminals (AREA)
  • Charge And Discharge Circuits For Batteries Or The Like (AREA)
  • Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
  • Optical Integrated Circuits (AREA)
  • Transplanting Machines (AREA)
  • Orthopedics, Nursing, And Contraception (AREA)
  • Steam Or Hot-Water Central Heating Systems (AREA)
  • Securing Of Glass Panes Or The Like (AREA)
  • Detergent Compositions (AREA)
LVP-93-627A 1986-12-19 1993-06-19 Anti-vomit and sedative preparation for prevention of seasickness LV10185B (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
HU865338A HU197510B (en) 1986-12-19 1986-12-19 Process for producing pharmaceutical composition containing phenyl-alkyl-amine derivatives, against motion-sick
PCT/HU1987/000058 WO1988004552A1 (en) 1986-12-19 1987-12-18 Composition to prevent seasickness

Publications (2)

Publication Number Publication Date
LV10185A LV10185A (lv) 1994-10-20
LV10185B true LV10185B (en) 1995-04-20

Family

ID=10970131

Family Applications (1)

Application Number Title Priority Date Filing Date
LVP-93-627A LV10185B (en) 1986-12-19 1993-06-19 Anti-vomit and sedative preparation for prevention of seasickness

Country Status (26)

Country Link
US (1) US4925878A (de)
EP (1) EP0294441B1 (de)
JP (1) JP2534553B2 (de)
AT (1) ATE82847T1 (de)
BG (1) BG51918A1 (de)
CY (1) CY1740A (de)
CZ (1) CZ277831B6 (de)
DD (1) DD264851A5 (de)
DE (1) DE3782935T2 (de)
DK (1) DK464788A (de)
ES (1) ES2009228A6 (de)
FI (1) FI883837L (de)
GE (1) GEP19970949B (de)
GR (1) GR871953B (de)
HK (1) HK105193A (de)
HU (1) HU197510B (de)
IL (1) IL84786A (de)
LT (1) LT4007B (de)
LV (1) LV10185B (de)
MD (1) MD408C2 (de)
MX (1) MX9203088A (de)
PT (1) PT86406B (de)
RU (1) RU1825314C (de)
SK (1) SK278500B6 (de)
UA (1) UA19281A1 (de)
WO (1) WO1988004552A1 (de)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4861800A (en) * 1987-08-18 1989-08-29 Buyske Donald A Method for administering the drug deprenyl so as to minimize the danger of side effects
CS269271B1 (en) * 1988-05-30 1990-04-11 Hajicek Josef Method of selegiline's hydrochloride production
HU208484B (en) * 1988-08-17 1993-11-29 Chinoin Gyogyszer Es Vegyeszet Process for producing pharmaceutical composition containing acid additional salt of selegilin as active component for treating schisofrenia
US5744500A (en) 1990-01-03 1998-04-28 Teva Pharmaceutical Industries, Ltd. Use of R-enantiomer of N-propargyl-1-aminoindan, salts, and compositions thereof
US5844003A (en) * 1991-04-04 1998-12-01 Innovations Foundation Use of deprenyl compounds to maintain, prevent loss, or recover nerve cell function
EP1413299A3 (de) * 1991-04-04 2004-05-06 The University Of Toronto Innovations Foundation Verwendung von Deprenyl Analoga zur Unterhaltung,Verhinderung von Verlust oder Zurückgewinnung von Nervenzellefunktion
US5444095A (en) * 1991-04-04 1995-08-22 University Of Toronto, Innovations Foundation Use of deprenyl to rescue damaged nerve cells
US5767164A (en) * 1991-04-04 1998-06-16 Innovations Foundation Use of deprenyl to rescue damaged nerve cells
HUT63579A (en) * 1991-12-20 1993-09-28 Chinoin Gyogyszer Es Vegyeszet Process for producing double-phase pharmaceutical compositions suitable for treating diseases occurring during neurodegenerative processes
US5242950A (en) * 1992-04-23 1993-09-07 Somerset Pharmaceuticals, Inc. Treatment of macular degeneration
US5817336A (en) * 1993-04-02 1998-10-06 Orion-Yhtyma Oy Composition containing selegiline
FR2704756B1 (fr) * 1993-05-04 1995-07-28 Sanofi Elf Utilisation de la sélégiline en médecine vétérinaire.
ES2149850T3 (es) * 1993-05-04 2000-11-16 Ceva Sante Animale Utilizacion de la selegilina en medicina veterinaria.
GB2280604B (en) * 1993-07-02 1997-04-30 Resource Medical Limited Processing of active agents
EP0762877B1 (de) 1994-06-03 2001-03-21 THEJMDE Trust Meta substituierte arylalkylamine und therapeutische und diagnostische verwendung davon
US6319954B1 (en) 1995-01-13 2001-11-20 Somerset Pharmaceuticals, Inc. S-(+)-desmethylselegiline and its use in the therapeutic methods and pharmaceutical compositions
US6033682A (en) 1995-01-13 2000-03-07 Somerset Pharmaceuticals, Inc. S(+) desmethylselegiline and its use in therapeutic methods and pharmaceutical compositions
US6348208B1 (en) * 1995-01-13 2002-02-19 Somerset Pharmaceuticals, Inc. Methods and pharmaceutical compositions employing desmethylselegiline
US6299901B1 (en) 1995-01-13 2001-10-09 Somerset Pharmaceuticals, Inc. Methods and pharmaceutical compositions employing desmethylselegiline
WO1996024346A1 (en) * 1995-02-10 1996-08-15 The University Of Toronto Innovations Foundation Deprenyl compounds for treatment of glaucoma
ATE241346T1 (de) * 1995-03-02 2003-06-15 Scherer Technologies Inc R P Arzneimittel enthaltend monoaminooxidase-b-hemmer
DE19716905C1 (de) * 1997-04-22 1998-08-27 Iip Inst Fuer Ind Pharmazie Fo Stabile, wäßrige Lösung auf der Grundlage von Selegilin und Vorrichtung zu ihrer Verabreichung
US6042533A (en) 1998-07-24 2000-03-28 Kania; Bruce Apparatus and method for relieving motion sickness
US6197329B1 (en) 1999-05-03 2001-03-06 Drugtech Corporation Anti-nausea compositions and methods
US6443913B1 (en) 2000-03-07 2002-09-03 Bruce Kania Apparatus and method for relieving motion sickness
US6497649B2 (en) * 2001-01-21 2002-12-24 University Of Washington Alleviating motion, simulator, and virtual environmental sickness by presenting visual scene components matched to inner ear vestibular sensations
US7128705B2 (en) * 2002-11-26 2006-10-31 Artis Llc Motion-coupled visual environment for prevention or reduction of motion sickness and simulator/virtual environment sickness
AT16235U1 (de) * 2018-06-21 2019-04-15 Dr Reinhart Jarisch Kaugummi enthaltend Vitamin C

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1031425A (en) * 1962-03-30 1966-06-02 Chinoin Gyogyszer Es Vegyeszet New aralkylamines and their preparation
DE1227447B (de) * 1962-03-30 1966-10-27 Chinoin Gyogyszer Es Vegyeszet Verfahren zur Herstellung von Phenylisopropylaminen
ES2092707T3 (es) 1992-04-10 1996-12-01 Schott Glaswerke Vidrio cristalino exento de plomo y bario con elevada transmision de la luz.

Also Published As

Publication number Publication date
UA19281A1 (uk) 1997-12-25
WO1988004552A1 (en) 1988-06-30
GEP19970949B (en) 1997-03-31
PT86406A (en) 1988-01-01
LT4007B (en) 1996-07-25
US4925878A (en) 1990-05-15
DD264851A5 (de) 1989-02-15
FI883837A7 (fi) 1988-08-18
DE3782935T2 (de) 1993-04-08
CY1740A (en) 1995-10-20
EP0294441B1 (de) 1992-12-02
HK105193A (en) 1993-10-15
GR871953B (en) 1988-04-19
LTIP1849A (en) 1995-08-25
CZ277831B6 (en) 1993-06-16
SK278500B6 (en) 1997-07-09
BG51918A1 (en) 1993-11-15
HUT45196A (en) 1988-06-28
JP2534553B2 (ja) 1996-09-18
RU1825314C (ru) 1993-06-30
LV10185A (lv) 1994-10-20
ATE82847T1 (de) 1992-12-15
FI883837A0 (fi) 1988-08-18
IL84786A (en) 1991-08-16
MX9203088A (es) 1992-07-01
DK464788D0 (da) 1988-08-18
ES2009228A6 (es) 1989-09-16
EP0294441A1 (de) 1988-12-14
PT86406B (pt) 1990-11-20
MD408C2 (ro) 1996-07-31
CS8709491A1 (en) 1990-05-14
HU197510B (en) 1989-04-28
JPH01501626A (ja) 1989-06-08
DK464788A (da) 1988-08-18
DE3782935D1 (de) 1993-01-14
FI883837L (fi) 1988-08-18

Similar Documents

Publication Publication Date Title
LV10185B (en) Anti-vomit and sedative preparation for prevention of seasickness
Andrews et al. Genetic factors in stuttering confirmed.
HU0201264D0 (de)
PT71861B (en) Process for preparing long lasting agonists and agonists of lhrh
MY107661A (en) Improved anti-plaque compositions comprising a combination of morpholioamino alcohol and metal salts
TW252971B (de)
AU557898B2 (en) Aminoethoxybenzylalcohol derivatives
GR851467B (de)
JPS6470461A (en) Novel pyrrolidine-2,5-dione and 4,5,6,7- tetrahydroisoindole-1,3-dione and herbicidal composition
MX171025B (es) Composicion oral para inhibir la placa dental humana
EP0112587A3 (en) Derivatives of 4-(1-(phenyl)-1-(hydroxy)-prop-1-yl)-resorcine, process for their preparation and medicines containing these compounds
WO1998002415A3 (en) Method for inhibiting corrosion and process for preparing 1-amidoalkylimidazoles
Perry et al. Phase I safety trial of soluble complement receptor type I (TP 10) in acute myocardial infarction
Wise Storage period ends for 4000 embryos.
GR79150B (de)
NL8204063A (nl) Farmakologische 4-fenyl-4-oxo-2-buteenzuurderivaten alsmede deze derivaten bevattende farmaceutische preparaten.
Schall Comparison of Medical and Industrial Radiography
Wee Purification, characterization and regulation of testicular temperature labile cholesterol ester hydrolase.
Nakahara et al. Glucosyltransferase inhibitors, as well as dental caries prevention methods and anticarious foods using the same
Rowe Growth hormone research back on track.
MX174421B (es) Procedimiento para la preparacion de 4-arilcarbonil-1-[(4-morfolinil)-alquilo-inferior]-1h-indoles y producto obtenido
JPS62652B2 (de)
Horikoshi et al. Cell-associated glucosyltransferase, an antibody thereto, and a dental caries prophylactic composition containing said antibody as an effective component
McBride US smoking battles heat up.
Helen The challenge of operating in the new Europe. case study-fresh produce